Respiratory syncytial virus (RSV) causes respiratory disease and complications in infants,
the elderly and the immunocompromised. While three vaccines and two prophylactic …

Respiratory syncytial virus (RSV) stands as the foremost cause of infant hospitalization
globally, ranking second only to malaria in terms of infant mortality. Although three vaccines …

Abstract The Nipah virus (NiV), a member of the Paramyxoviridae family, is notorious for its
high fatality rate in humans. The RNA polymerase machinery of NiV, comprising the large …

Nipah virus (NiV) is a bat-borne, zoonotic RNA virus that is highly pathogenic in humans.
The NiV polymerase, which mediates viral genome replication and mRNA transcription, is a …

Respiratory syncytial virus (RSV) is an RNA virus infecting the upper and lower respiratory
tract and is recognized as a major respiratory health threat, particularly to older adults …

Small-molecule antivirals can be used as chemical probes to stabilize transitory
conformational stages of viral target proteins, facilitating structural analyses. Here, we …

The transcription and replication processes of non-segmented, negative-strand RNA viruses
(nsNSVs) are catalyzed by a multi-functional polymerase complex composed of the large …

The Mononegavirales, or non-segmented negative-sense RNA viruses (nsNSVs), includes
significant human pathogens, such as respiratory syncytial virus, parainfluenza virus …

Despite the availability of medicines preventing respiratory syncytial virus (RSV) infection,
post-exposure treatment options are needed for addressing patient's needs. RSV non …

Summary Respiratory Syncytial Virus (RSV) causes severe respiratory infections and
concomitant disease resulting in significant morbidity and mortality in infants, elderly, and …